Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with Cutaneous Lupus Erythematosus are young females, and dermatologists play a key role in diagnosis.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Most lupus patients in coastal Kerala had skin-specific lesions that could help diagnose the disease, and non-specific skin issues were linked to more severe, systemic lupus.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Methotrexate treats various disorders by inhibiting DNA synthesis, but careful monitoring is needed to avoid toxicity and manage side effects.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Combining systemic and topical treatments, guided by weekly fungal cultures, effectively treats cat ringworm.

Cosmetics enhance beauty, fix defects, and intimidate enemies, with varying cultural standards and alternative methods.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Healthcare workers in Turkey experienced more skin problems due to frequent handwashing and wearing masks and gloves during the COVID-19 outbreak.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

The document concludes that veterinary dermatologists need more experience and a better approach to treating skin diseases in nonhuman primates.

Better awareness of chemotherapy's side effects improves self-care.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

SLE patients experience two patterns of non-inflammatory symptoms: intermittent and persistent.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

The mtDNA N haplogroup is linked to a higher risk of late-onset lupus and specific symptoms in Han Chinese women.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

A 3-year-old boy lost all his hair due to a rare reaction to phenobarbital, but it grew back after steroid treatment.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

Nitrofurantoin may cause sub-acute cutaneous lupus erythematosus.